530125 On Other Exchanges
Symbol
Exchange
530125 is not on other exchanges.

samrat pharmachem ltd (530125) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SAMRAT PHARMACHEM LTD (530125)

Related News

No related news articles were found.

samrat pharmachem ltd (530125) Related Businessweek News

No Related Businessweek News Found

samrat pharmachem ltd (530125) Details

Samrat Pharmachem Limited produces and sells pharmaceutical chemicals in India. The company primarily sells iodine and bromine salts. Its products include calcium iodate monohydrate, copper iodide, hydriodic acid, iodine, iodine monochloride, iodoethane, iodomethane, potassium bromide, potassium iodate, potassium iodide, potassium metaperiodate, sodium iodate, sodium iodide, sodium metaperiodate, and trimethyl sulfoxoniumiodide. The company’s finished products are primarily used in various industries, including pharmaceuticals, chemicals, food, fertilizer, salt, etc. Samrat Pharmachem Limited also exports its products. The company was incorporated in 1992 and is based in Mumbai, India.

Founded in 1992

samrat pharmachem ltd (530125) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: 1.5M
Executive Director of Finance, Executive Dire...
Total Annual Compensation: 1.4M
Compensation as of Fiscal Year 2015.

samrat pharmachem ltd (530125) Key Developments

Samrat Pharmachem Limited Announces Auditor Changes

Samrat Pharmachem Limited announced that the Statutory Auditors of the Company Messrs. Shah, Shah & Shah, Chartered Accountants has resigned due to their preoccupation with effect from 12 August, 2016. The company appointed new auditors Messrs. Shah & Savla LLP, Chartered Accountants with effect from August 22, 2016 in casual vacancy caused due to resignation of Messrs. Shah, Shah & Shah, Chartered Accountants to hold office till the conclusion of next Annual General Meeting of the Company.

Samrat Pharmachem Limited, Annual General Meeting, Sep 24, 2016

Samrat Pharmachem Limited, Annual General Meeting, Sep 24, 2016, at 13:00 Indian Standard Time. Location: Plot no.A2/3445,GIDC,Phase 4 Ankleshwar-393002 Gujarat India Agenda: To consider the adoption of profit and loss, balance sheet, report of board of directors and auditors; to re-appoint directors; to appoint of statutory auditors; and to consider other issues.

Samrat Pharmachem Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2016

Samrat Pharmachem Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net income from sales/services of INR 212.748 million against INR 125.656 million a year ago. Profit from operations before other income, interest and exceptional items was INR 5.135 million against INR 1.503 million a year ago. Profit from ordinary activities before tax was INR 3.918 million against INR 1.199 million a year ago. Net profit for the period was INR 2.488 million against INR 0.717 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 0.81 against INR 0.23 a year ago.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

530125 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 530125.
View Industry Companies
 

Industry Analysis

530125

Industry Average

Valuation 530125 Industry Range
Price/Earnings 25.2x
Price/Sales 0.2x
Price/Book 0.9x
Price/Cash Flow 13.0x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SAMRAT PHARMACHEM LTD, please visit www.samratpharmachem.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.